InvestSMART

Polynovo Limited (ASX: PNV) - Announcements

- Current share price for PNV : $0.905

ASX company news and announcements for Polynovo Limited (PNV) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Polynovo Limited (PNV) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Polynovo Limited (PNV), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Polynovo Limited (PNV)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$625 NovoSorb BTM registered with TGA 14 Aug 2018 1:52PM $0.520 $0.905 risen by 74.04%
$625 Final Patient enrolled in BARDA Feasibility Burn Trial 2 Aug 2018 2:27PM $0.510 $0.905 risen by 77.45%
$625 NovoSorb BTM approved for sale in Saudi Arabia 27 Jul 2018 8:21AM $0.480 $0.905 risen by 88.54%
$625 PolyNovo offers World Class skin product to Greek Fire 26 Jul 2018 11:44AM $0.485 $0.905 risen by 86.60%
$625 Corporate Governance Statement - Year Ending 30 June 2017 27 Jun 2018 10:17AM $0.530 $0.905 risen by 70.75%
$625 Ceasing to be a substantial holder 14 Jun 2018 2:06PM $0.560 $0.905 risen by 61.61%
$625 Final patient enrolled in CE Mark Burn Trial 22 May 2018 3:22PM $0.550 $0.905 risen by 64.55%
$625 Change in substantial holding 15 May 2018 12:17PM $0.540 $0.905 risen by 67.59%
$625 Change of Director's Interest Notice 15 May 2018 9:15AM $0.540 $0.905 risen by 67.59%
$625 Change of Director's Interest Notice 10 May 2018 9:38AM $0.515 $0.905 risen by 75.73%
$625 Appendix 3B 2 May 2018 3:22PM $0.515 $0.905 risen by 75.73%
$625 Change of Director's Interest Notice 1 May 2018 2:06PM $0.515 $0.905 risen by 75.73%
$625 Change of Director's Interest Notice 30 Apr 2018 9:40AM $0.500 $0.905 risen by 81%
$625 PolyNovo Announces Breast Device Development Program 3 Apr 2018 10:08AM $0.530 $0.905 risen by 70.75%
$625 Change in substantial holding 27 Mar 2018 12:36PM $0.480 $0.905 risen by 88.54%
$625 Change of Director's Interest Notice 27 Mar 2018 9:40AM $0.480 $0.905 risen by 88.54%
$625 Resignation of Joint Company Secretary 20 Feb 2018 3:37PM $0.500 $0.905 risen by 81%
$625 Results announcement, App 4D and Half-Year Financial Report 15 Feb 2018 11:27AM $0.525 $0.905 risen by 72.38%
$625 First US Surgeon Podium presentations of Novosorb BTM 1 Feb 2018 8:56AM $0.480 $0.905 risen by 88.54%
$625 COO, CFO and Company Secretary 23 Jan 2018 4:20PM $0.540 $0.905 risen by 67.59%
$625 PolyNovo Announces Breast Device Development Agreement 18 Jan 2018 9:50AM $0.570 $0.905 risen by 58.77%
$625 Hong Kong Investor Presentation 14 Dec 2017 8:21AM $0.420 $0.905 risen by 115.48%
$625 CEO Presentation - Financial News Network CEO Sessions 21 Nov 2017 9:30AM $0.360 $0.905 risen by 151.39%
$625 Results of Meeting 16 Nov 2017 5:46PM $0.350 $0.905 risen by 158.57%
$625 Chairman's Address to Shareholders 16 Nov 2017 12:51PM $0.350 $0.905 risen by 158.57%

501 - 525 of 671 results

Page 21 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.